Maisonneuve-Rosemont Hospital

Montreal H1T 2M4

1 studies enrolling now · 2 studies all time

What they study most

D-dimer, Deep Venous Thrombosis, End Stage Kidney Disease, Pulmonary Embolism

Studies at this site

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism — Completed